Capstone Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Sell |
18,900
-85,800
| -82% | -$6.61M | ﹤0.01% | 753 |
|
|
2025
Q4 | $8.31M | Sell |
104,700
-44,100
| -30% | -$3.48M | 0.02% | 295 |
|
|
2025
Q3 | $11.2M | Buy |
148,800
+62,500
| +72% | +$4.28M | 0.02% | 301 |
|
|
2025
Q2 | $5.95M | Sell |
86,300
-11,900
| -12% | -$780K | 0.01% | 359 |
|
|
2025
Q1 | $6.65M | Sell |
98,200
-67,600
| -41% | -$4.05M | 0.02% | 387 |
|
|
2024
Q4 | $7.44M | Buy |
165,800
+117,800
| +245% | +$6.61M | 0.02% | 425 |
|
|
2024
Q3 | $3.02M | Sell |
48,000
-9,300
| -16% | -$543K | 0.01% | 602 |
|
|
2024
Q2 | $3.38M | Sell |
57,300
-37,900
| -40% | -$2.37M | 0.01% | 566 |
|
|
2024
Q1 | $7.59M | Sell |
95,200
-55,800
| -37% | -$4.26M | 0.03% | 326 |
|
|
2023
Q4 | $11.9M | Buy |
151,000
+46,800
| +45% | +$3.33M | 0.04% | 311 |
|
|
2023
Q3 | $7.28M | Sell |
104,200
-2,600
| -2% | -$184K | 0.03% | 344 |
|
|
2023
Q2 | $7.38M | Sell |
106,800
-123,400
| -54% | -$8.78M | 0.04% | 298 |
|
|
2023
Q1 | $17.1M | Buy |
230,200
+195,600
| +565% | +$16.4M | 0.09% | 152 |
|
|
2022
Q4 | $3.22M | Buy |
34,600
+1,700
| +5% | +$164K | 0.02% | 539 |
|
|
2022
Q3 | $3.14M | Buy |
32,900
+3,000
| +10% | +$297K | 0.02% | 567 |
|
|
2022
Q2 | $2.77M | Sell |
29,900
-92,800
| -76% | -$9.06M | 0.01% | 640 |
|
|
2022
Q1 | $12.4M | Sell |
122,700
-262,700
| -68% | -$27.6M | 0.03% | 393 |
|
|
2021
Q4 | $39.8M | Buy |
385,400
+16,400
| +4% | +$1.52M | 0.07% | 258 |
|
|
2021
Q3 | $31.3M | Buy |
369,000
+5,500
| +2% | +$461K | 0.06% | 296 |
|
|
2021
Q2 | $30.3M | Buy |
363,500
+46,600
| +15% | +$3.82M | 0.07% | 259 |
|
|
2021
Q1 | $23.8M | Buy |
316,900
+142,800
| +82% | +$10.4M | 0.07% | 257 |
|
|
2020
Q4 | $11.9M | Sell |
174,100
-22,100
| -11% | -$1.44M | 0.04% | 351 |
|
|
2020
Q3 | $11.5M | Buy |
196,200
+157,600
| +408% | +$9.81M | 0.06% | 286 |
|
|
2020
Q2 | $2.51M | Buy |
38,600
+29,700
| +334% | +$1.87M | 0.02% | 636 |
|
|
2020
Q1 | $528K | Sell |
8,900
-209,100
| -96% | -$14M | 0.01% | 876 |
|
|
2019
Q4 | $16.2M | Buy |
218,000
+27,800
| +15% | +$1.95M | 0.09% | 244 |
|
|
2019
Q3 | $12M | Sell |
190,200
-65,000
| -25% | -$3.85M | 0.08% | 246 |
|
|
2019
Q2 | $13.9M | Buy |
255,200
+163,900
| +180% | +$8.83M | 0.1% | 212 |
|
|
2019
Q1 | $4.92M | Buy |
91,300
+34,200
| +60% | +$2.11M | 0.05% | 359 |
|
|
2018
Q4 | $3.74M | Buy |
57,100
+37,700
| +194% | +$2.81M | 0.05% | 313 |
|
|
2018
Q3 | $1.53M | Sell |
19,400
-40,100
| -67% | -$2.87M | 0.02% | 490 |
|
|
2018
Q2 | $3.83M | Buy |
+59,500
| New | +$3.92M | 0.06% | 183 |
|
|
2017
Q2 | – | Sell |
-10,500
| Closed | -$822K | – | 685 |
|
|
2017
Q1 | $822K | Sell |
10,500
-3,300
| -24% | -$263K | 0.02% | 472 |
|
|
2016
Q4 | $1.09M | Buy |
+13,800
| New | +$1.12M | 0.03% | 395 |
|
Other funds holding CVS
VCM
VPM
Capstone Investment Advisors's CVS Position: Q1 2026 in Review
Capstone Investment Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 6,411 shares — an estimated $494K sold.
Capstone Investment Advisors first reported a position in CVS in Q2 2014 and held it in 29 quarters. The position peaked at $12.2M in Q2 2023. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Capstone Investment Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
- Capstone Investment Advisors sold 6,411 CVS Health shares in Q1 2026, an estimated $494K.
- Capstone Investment Advisors first reported a position in CVS Health in Q2 2014 and held it in 29 quarters.
- Capstone Investment Advisors's CVS Health position peaked at $12.2M in Q2 2023.
- 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.